Package 27241-205-30

Brand: brexpiprazole

Generic: brexpiprazole
NDC Package

Package Facts

Identity

Package NDC 27241-205-30
Digits Only 2724120530
Product NDC 27241-205
Description

30 TABLET in 1 BOTTLE (27241-205-30)

Marketing

Marketing Status
Marketed Since 2023-02-03
Brand brexpiprazole
Generic brexpiprazole
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "430dc8c4-7349-42d5-9036-b0bdcc02a839", "openfda": {"nui": ["N0000175430"], "upc": ["0327241205309", "0327241208300", "0327241209307", "0327241206306", "0327241207303", "0327241204302"], "unii": ["2J3YBM1K8C"], "rxcui": ["1658319", "1658327", "1658331", "1658335", "1658339", "1658343"], "spl_set_id": ["993b584c-7fe6-4551-899f-39146c8508ac"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "manufacturer_name": ["Ajanta Pharma USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (27241-205-30)", "package_ndc": "27241-205-30", "marketing_start_date": "20230203"}], "brand_name": "Brexpiprazole", "product_id": "27241-205_430dc8c4-7349-42d5-9036-b0bdcc02a839", "dosage_form": "TABLET", "pharm_class": ["Atypical Antipsychotic [EPC]"], "product_ndc": "27241-205", "generic_name": "Brexpiprazole", "labeler_name": "Ajanta Pharma USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Brexpiprazole", "active_ingredients": [{"name": "BREXPIPRAZOLE", "strength": ".5 mg/1"}], "application_number": "ANDA213718", "marketing_category": "ANDA", "marketing_start_date": "20230203", "listing_expiration_date": "20261231"}